Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them

Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them

US Patent 10913726 · Granted Feb 9, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Centrally active and orally bioavailable uncharged bisoxime antidotes for organo2023
Centrally active and orally bioavailable uncharged bisoxime antidotes for organo2023
Centrally active and orally bioavailable antidotes for organophosphate exposure 2020
Centrally active and orally bioavailable antidotes for organophosphate exposure 2020
Centrally active and orally bioavailable antidotes for organophosphate exposure 2020
Centrally active and orally bioavailable antidotes for organophosphate exposure 2020
Selective alpha-7 nicotinic receptor agonists and methods for making and using t2019
Selective alpha-7 nicotinic receptor agonists and methods for making and using t2019
Selective alpha-7 nicotinic receptor agonists and methods for making and using t2019
Catalytic scavengers of organophosphates to potentiate butyrylcholinesterase (hB2019
Catalytic scavengers of organophosphates to potentiate butyrylcholinesterase (hB2019
Catalytic scavengers of organophosphates to potentiate butyrylcholinesterase (hB2019